The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment
References (112)
- et al.
Gallium-67 scanning: Limited usefulness in staging patients with non-Hodgkin's lymphoma
Am J Med
(1980) - et al.
The role of gallium-67 in the clinical evaluation of cancer
- et al.
High-dose gallium imaging in lymphoma
Am J Med
(1983) - et al.
A comparison of gallium-67 single photon emission computed tomography and computed tomography in mediastinal Hodgkin's disease
Eur J Cancer
(1992) - et al.
The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients
- et al.
The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy
Ann Oncol
(1994) - et al.
Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation
Am J Med
(1989) - et al.
PET imaging in oncology
- et al.
Increased glucose metabolism in untreated non-Hodgkin's lymphoma: A study with positron emission tomography and fluorine-18-fluorodeoxyglucose
Blood
(1995) - et al.
Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type
Ann Oncol
(1999)
Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease
Ann Oncol
Positron emission tomography in lymphoma: Comparison with computed tomography and gallium-67 single photon emission computed tomography
Clin Lymphoma
Detection of lymphoma in bone marrow by whole-body positron emission tomography
Blood
The role of positron emission tomography (PET) in the management of lymphoma patients
Ann Oncol
Tumor scanning with Ga-67 citrate
J Nucl Med
Gallium-67 localization in rat and mouse tumors
Science
Uptake of Gallium-67 citrate and [2–3H] deoxyglucose in the tumor model, following chemotherapy and radiotherapy
J Nucl Med
Lymphoma
Distribution of Gallium-67 in normal and hypotransferrinemic tumor-bearing mice
J Nucl Med
Gallium scintigraphy in tumor diagnosis and management
Ga-67 scintigraphy in B-cell non-Hodgkin's lymphoma: Correlation of Ga-67 uptake with histology and transferrin receptor expression
J Nucl Med
Gallium-67 citrate imaging in Hodgkin's disease: Final report of cooperative group
J Nucl Med
Ga-67 citrate imaging in malignant lymphoma: Final report of cooperative group
J Nucl Med
Gallium-67 citrate scanning
Arch Intern Med
The relative roles of gallium-67-citrate scanning and lymphangiography in the current management of malignant lymphoma
Cancer
Ga-67 SPECT before and after treatment of lymphoma
Radiology
Lymphoma: Evaluation with Ga-67 SPECT
Radiology
Gallium scintigraphy in American Burkitt lymphoma: Accurate assessment of tumor load and prognosis
AJR Am J Roentgenol
Gallium-67 seintigraphy in untreated and treated non-Hodgkin lymphomas
J Nucl Med
Status of gallium-67 in tumor detection
J Nucl Med
The role of gallium-67 scintigraphy in patients with small, non-cleaved cell lymphoma
Eur J Nucl Med
Comparison of gallium-67 citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma
J Nucl Med
Revisiting the prognostic role of gallium scintigraphy in low-grade non-Hodgkin's lymphoma
Eur J Nucl Med
Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma
J Clin Oncol
The significance of the residual mediastinal mass in treated Hodgkin's disease
J Clin Oncol
The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease
J Clin Oncol
Residual abdominal massess in aggressive non-Hodgkin's lymphoma after combination chemotherapy: Significance and management
J Clin Oncol
Residual mass in lymphoma may not be residual disease
J Clin Oncol
Gallium-67 imaging in monitoring lymphoma response to treatment
Cancer
Gallium scanning in the management of mediastinal Hodgkin's disease
Eur J Haematol
Residual mass and negative gallium scintigraphy in treated lymphoma
J Nucl Med
Lymphoma of the mediastinum and neck: Evaluation with Ga-67 imaging and CT correlation
Radiology
Gallium-67 scan as an adjunct to computed tomography scans for the assessment of a residual mediastinal mass in pediatric patients with Hodgkin's disease
Cancer
Validation of gallium-67-citrate single photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum
J Nucl Med
The dilemma of a residual mass in treated lymphoma: The role of gallium-67 scintigraphy
Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patients
Med Oncol
Alteration of gallium-67 distribution in tumor-bearing mice following treatment with methotrexate: Concise communication
J Nucl Med
Loss of radio-gallium from lymphoma after initiation of chemotherapy
Clin Nucl Med
Residual mass and negative gallium scintigraphy in treated lymphoma: When is the gallium scan really negative?
J Nucl Med
High frequency of benign mediastinal uptake of gallium-67 after completion of chemotherapy in children with high grade non-Hodgkin's lymphoma
J Clin Oncol
Cited by (60)
Gamma camera imaging in hematological diseases
2022, Nuclear Medicine and Molecular Imaging: Volume 1-4Gallium: New developments and applications in radiopharmaceutics
2021, Advances in Inorganic ChemistryCitation Excerpt :67Ga imaging was first used to image lymphoma in the 1970s.4 However, 67Ga-citrate imaging of lymphoma with planar scintigraphy has largely been superseded by 18F-fluorodeoxyglucose (FDG) imaging with positron emission tomography (PET).2 The same is true to an extent for infection imaging, despite the much lower specificity of FDG imaging in this context.
Rebound (reactive) thymic hyperplasia after chemotherapy in children with lymphoma
2019, Anales de PediatriaThe impact of radiation therapy in patients with diffuse large B-cell lymphoma with positive post-chemotherapy FDG-PET or gallium-67 scans
2011, Annals of OncologyCitation Excerpt :Similar to PET imaging, gallium scans are also superior to CT in predicting residual disease after chemotherapy [7]. However, PET scans are now preferred because the accuracy of gallium scans can vary based on technique and they have a lower accuracy in detecting intra-abdominal disease due to uptake in the bowel [19]. Several studies have demonstrated that a positive PET after completion of chemotherapy for NHL is a strong predictor of subsequent treatment failure in patients who do not receive consolidation RT.
Imaging of Pediatric Lymphomas
2008, Radiologic Clinics of North AmericaCitation Excerpt :Whole-body imaging also may be performed using nuclear medicine imaging with gallium 67 or with positron emission tomography (PET) using fluorodeoxyglucose (FDG). Gallium is well known to be positive in lymphoma, and gallium scanning with single photon emission CT (SPECT) enhances lesion conspicuity.55 Recent studies have confirmed the increased sensitivity of PET compared with gallium in diagnosis and follow-up of pediatric lymphoma.56–62